Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

RELMADA THERAPEUTICS, INC. (RLMD)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-Q10-Q10-Q10-Q
Net income       -112.1-86.4-71.0
Depreciation and amortization   [+]      0.00.0
Stock-based compensation       25.322.621.6
Change in working capital   [+]     14.510.49.8
Other operating activities       11.20.8-0.9
Cash from operations       -61.1-52.7-40.5
   
Capital expenditures       0.00.00.0
Sales of short-term investments       119.544.036.1
Other cash from investing       -81.5-29.0-31.5
Cash from investing       38.015.14.7
   
Issuance of common stock, net       23.443.2 
Other cash from financing       3.8-14.08.3
Cash from financing       27.028.527.4
   
Free cash flow       -61.1-52.7-40.5
        Per share (diluted)       ($3.67)($3.23)($2.55)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy